ORBCOMM’s Euroscan Product Line of Temperature Recording Devices and Cold Chain Monitoring Solutions Validated to GAMP® 5 Guidelines

Confirms Euroscan’s products meet the requirements to support customers that store and transport pharmaceuticals throughout Europe

ROCHELLE PARK, N.J.--()--ORBCOMM Inc. (Nasdaq: ORBC), a global provider of Machine-to-Machine (M2M) solutions, today announced that its Euroscan product line of temperature recording devices and cold chain monitoring systems is now fully validated to the Good Automated Manufacturing Practice (GAMP® 5) guidelines. GAMP 5 guidelines are published by the International Society for Pharmaceutical Engineering (ISPE) and provide a flexible, risk-based approach on how to define and implement quality procedures, including compliant computerized systems, that support Good Distribution Practices (GDP) of pharmaceutical products for human use.

“ORBCOMM’s industry-leading cold chain solutions not only provide reliable temperature monitoring, fuel management, maintenance, and remote control functionality for refrigerated assets, but also enable our customers to improve operational efficiency, enhance customer satisfaction and meet their regulatory requirements for quality assurance.”

ORBCOMM has enhanced, tested and implemented the processes and documentation to demonstrate that the Euroscan product line can be validated by GAMP 5 guidelines. This validation confirms that ORBCOMM’s Euroscan products are a reliable choice for customers that need to gain complete traceability of their operations, report storage conditions, including deviations in temperature settings, and protect the quality and integrity of their refrigerated assets throughout the European supply chain. As part of this comprehensive process, ORBCOMM’s Euroscan products passed a thorough audit by the European Institute for Pharma Logistics (EIPL), to further support its compliance with GAMP 5 guidelines.

“We are pleased to receive confirmation that our products follow GAMP 5 methodology, which enables us to support our pharmaceutical customers in Europe at every point in the transportation path,” said Ron Quaedvlieg, ORBCOMM’s Managing Director of Euroscan. “ORBCOMM’s industry-leading cold chain solutions not only provide reliable temperature monitoring, fuel management, maintenance, and remote control functionality for refrigerated assets, but also enable our customers to improve operational efficiency, enhance customer satisfaction and meet their regulatory requirements for quality assurance.”

EIPL’s certification of ORBCOMM’s compliance to GAMP 5 guidelines is available upon request by contacting info@euroscangroup.com.

About ORBCOMM Inc.

ORBCOMM Inc. (Nasdaq: ORBC) is a leading global provider of Machine-to-Machine (M2M) communication solutions and the only commercial satellite network dedicated to M2M. ORBCOMM’s unique combination of global satellite, cellular and dual-mode network connectivity, hardware, web reporting applications and software is the M2M industry’s most complete service offering. Our solutions are designed to remotely track, monitor, and control fixed and mobile assets in core vertical markets including transportation & distribution, heavy equipment, industrial fixed assets, oil & gas, maritime, mining and government.

With nearly 20 years of innovation and expertise in M2M, ORBCOMM has more than 1.2 million subscribers with a diverse customer base including premier OEMs such as Caterpillar Inc., Doosan Infracore America, Hitachi Construction Machinery Co., Ltd., John Deere, Komatsu Ltd., and Volvo Construction Equipment, as well as end-to-end solutions customers such as C&S Wholesale, Canadian National Railways, CR England, Hub Group, KLLM Transport Services, Marten Transport, Swift Transportation, Target, Tropicana, Tyson Foods, Walmart and Werner Enterprises. For more information, visit www.orbcomm.com.

Forward-Looking Statements

Certain statements discussed in this press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally relate to our plans, objectives and expectations for future events and include statements about our expectations, beliefs, plans, objectives, intentions, assumptions and other statements that are not historical facts. Such forward-looking statements, including those concerning the Company’s expectations, are subject to known and unknown risks and uncertainties, which could cause actual results to differ materially from the results, projected, expected or implied by the forward-looking statements, some of which are beyond the Company’s control, that may cause the Company’s actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. In addition, specific consideration should be given to various factors described in Part I, Item 1A. “Risk Factors” and Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2014, and other documents, on file with the Securities and Exchange Commission. The Company undertakes no obligation to publicly revise any forward-looking statements or cautionary factors, except as required by law.

Contacts

Investor Inquiries:
ORBCOMM Inc.
Michelle Ferris, 703-433-6516
Director of Corporate Communications
ferris.michelle@orbcomm.com
or
Financial and Trade Media:
The Abernathy MacGregor Group
Chuck Burgess, 212-371-5999
President
clb@abmac.com

Recent Stories

RSS feed for ORBCOMM Inc.

ORBCOMM Inc.